Science Explorer Back to mapMap
Discussion
Company · Leiden · Netherlands

Galapagos (Netherlands)

Research works
48
▲ 92% vs 2018-21
Citations
1.3k
26.9 per fractional work
Top-10% rate
9.4%
all institutions 10.0%
Open access
53%
world 40%
International
66%
world 18%

Not ranked overall: Galapagos (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Galapagos (Netherlands) work in?

In all years, 44% of research at Galapagos (Netherlands) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (7%). It does 2.3× the world's share of Life Sciences.

Health Sciences: 21 fractional works · 43.8% of its workMedicine: 21 fractional works · 43.1% of its workRheumatology: 4 fractional works · 7.7% of its workOncology: 3 fractional works · 6.6% of its workGenetics: 3 fractional works · 5.5% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.7% of its workHematology: 2 fractional works · 3.3% of its workPathology and Forensic Medicine: 2 fractional works · 3.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.2% of its workPharmacology: 1 fractional works · 1.8% of its workPhysiology: 0 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.9% of its workSurgery: 0 fractional works · 0.8% of its workEpidemiology: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workGastroenterology: 0 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.2% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.4% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 20 fractional works · 41.9% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 29.4% of its workMolecular Biology: 10 fractional works · 19.8% of its workGenetics: 3 fractional works · 7.0% of its workCell Biology: 1 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 0.7% of its workBiophysics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 6.8% of its workImmunology: 3 fractional works · 6.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 4.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.7% of its workBehavioral Neuroscience: 0 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 1.0% of its workPlant Science: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.2% of its workPhysical Sciences: 6 fractional works · 11.5% of its workEngineering: 2 fractional works · 4.4% of its workBiomedical Engineering: 1 fractional works · 2.7% of its workCivil and Structural Engineering: 0 fractional works · 0.7% of its workOcean Engineering: 0 fractional works · 0.7% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 1 fractional works · 2.5% of its workGeophysics: 1 fractional works · 2.5% of its workChemistry: 1 fractional works · 2.2% of its workOrganic Chemistry: 1 fractional works · 1.1% of its workInorganic Chemistry: 0 fractional works · 0.7% of its workAnalytical Chemistry: 0 fractional works · 0.2% of its workSpectroscopy: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workMaterials Science: 0 fractional works · 0.8% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 0.4% of its workGlobal and Planetary Change: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 2.8% of its workSocial Sciences: 1 fractional works · 1.4% of its workEducation: 0 fractional works · 0.5% of its workGeneral Social Sciences: 0 fractional works · 0.5% of its workSociology and Political Science: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.7% of its workEconomics and Econometrics: 0 fractional works · 0.7% of its workPsychology: 0 fractional works · 0.4% of its workSocial Psychology: 0 fractional works · 0.4% of its workArts and Humanities: 0 fractional works · 0.2% of its workArcheology: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKGalapagos(Netherlands)48fractional works, all years
Life Sciences42%Physical Sciences12%Health Sciences44%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine2143.1%
    2. Health Professions00.4%
    3. Nursing00.2%
    4. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology1429.4%
    2. Immunology and Microbiology36.8%
    3. Neuroscience24.1%
    4. Agricultural and Biological Sciences01.0%
    5. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Engineering24.4%
    2. Earth and Planetary Sciences12.5%
    3. Chemistry12.2%
    4. Computer Science00.9%
    5. Materials Science00.8%
    6. Mathematics00.4%
    7. Environmental Science00.4%
    1. Social Sciences11.4%
    2. Economics, Econometrics and Finance00.7%
    3. Psychology00.4%
    4. Arts and Humanities00.2%
    5. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.55× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.05× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.04× its world share, 1 worksImmunology and Micro…Neuroscience: 0.21× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.08× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.37× its world share, 0 worksChemistryComputer Science: 0.13× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 4.04× its world share, 1 worksEarth and Planetary …Engineering: 0.23× its world share, 1 worksEngineeringMathematics: 0.29× its world share, 0 worksMathematicsMedicine: 2.98× its world share, 11 worksMedicineNursing: 0.88× its world share, 0 worksNursingVeterinary: 2.54× its world share, 0 worksVeterinaryArts and Humanities: 0.20× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.63× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.0×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Immunology and Microbiology6.04×1 works
  2. Pharmacology, Toxicology and Pharmaceutics4.08×0 works
  3. Earth and Planetary Sciences4.04×1 works
  4. Biochemistry, Genetics and Molecular Biology3.05×3 works
  5. Medicine2.98×11 works
  6. Veterinary2.54×0 works
  7. Chemistry1.37×0 works
  8. Nursing0.88×0 works
  9. Economics, Econometrics and Finance0.63×0 works
  10. Agricultural and Biological Sciences0.55×0 works
  11. Mathematics0.29×0 works
  12. Engineering0.23×1 works
  13. Neuroscience0.21×0 works
  14. Arts and Humanities0.20×0 works
  15. Computer Science0.13×0 works

Who are the top researchers at Galapagos (Netherlands)?

Ranked on the quality score, Richard A. J. Janssen, Alessandra Faria Oortwijn and Claudia Beaurivage lead among researchers whose main affiliation is Galapagos (Netherlands).

  1. 1 Richard A. J. Janssen Netherlands · #520,089 worldwide 1.7k citations · 36 works
  2. 2 Alessandra Faria Oortwijn Netherlands · #1,072,520 worldwide 769 citations · 61 works
  3. 3 Claudia Beaurivage Netherlands · #1,775,768 worldwide 478 citations · 16 works
All ranked researchers at Galapagos (Netherlands)

What are the most cited papers from Galapagos (Netherlands)?

The most cited paper from Galapagos (Netherlands) is "Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours" (Angeliki Malliri, Rob A. van der Kammen, Kristopher P. Clark et al., 2002), with 386 citations. Next come "Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial" (258) and "Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial" (207).

Most cited papers
#PaperReleasedCitations
1 Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours Angeliki Malliri, Rob A. van der Kammen, Kristopher P. Clark et al. · Nature Jun 2002 386
2 Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial Désirée M F M van der Heijde, Xenofon Baraliakos, Lianne S. Gensler et al. · The Lancet Open access 22 Oct 2018 258
3 Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial Philip J. Mease, Laura C. Coates, Philip Helliwell et al. · The Lancet Open access 22 Oct 2018 207
4 The Orphan G Protein–Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons Amantha Thathiah, Kurt Spittaels, Marcel Hoffmann et al. · Science 12 Feb 2009 201
5 Development of a Gut-on-a-Chip Model for High Throughput Disease Modeling and Drug Discovery Claudia Beaurivage, Elena Naumovska, Yee Chang et al. · International Journal of Molecular Sciences Open access 12 Nov 2019 187
All 60 most cited papers, with filters and sorting

Which keywords describe research at Galapagos (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Gene Therapy, Cardiovascular Risk, Rituximab, Cancer Immunotherapy, Autoantibodies, Immunotherapy and Prognostic Factors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 5.0×17 topics
  2. Gene Therapy3▲ 26×3 topics
  3. Cancer3▲ 4.5×12 topics
  4. Cardiovascular Risk3▲ 18×4 topics
  5. Rituximab3▲ 39×3 topics
  6. Cancer Immunotherapy3▲ 43×3 topics
  7. Autoantibodies3▲ 24×4 topics
  8. Immunotherapy3▲ 8.3×4 topics
  9. Prognostic Factors3▲ 12×4 topics
  10. Lymphoma2▲ 34×2 topics
  11. Rheumatoid Arthritis2▲ 47×3 topics
  12. Chronic Lymphocytic Leukemia2▲ 92×1 topic
  13. Cytokines2▲ 17×2 topics
  14. Genomic Aberrations2▲ 92×1 topic
  15. Therapeutic Targets2▲ 19×2 topics
  16. Tumor Regression2▲ 52×2 topics
  17. Biological Therapy2▲ 77×1 topic
  18. Disease-Modifying Antirheumatic Drugs2▲ 88×1 topic
  19. CAR T Cells2▲ 89×1 topic
  20. Chimeric Antigen Receptor2▲ 89×1 topic
  21. Inflammatory Bowel Disease2▲ 34×3 topics
  22. AAV2▲ 49×1 topic
  23. Genetics2▲ 4.3×3 topics
  24. Viral Vectors2▲ 49×1 topic
  25. Cancer Therapy2▲ 4.9×5 topics
  26. Fibrosis2▲ 15×3 topics
  27. Immunology2▲ 26×2 topics
  28. Pathogenesis2▲ 5.4×2 topics
  29. RNA Interference2▲ 27×1 topic
  30. siRNA Delivery2▲ 40×1 topic
  31. Crohn's Disease1▲ 37×1 topic
  32. Ulcerative Colitis1▲ 84×1 topic
  33. Genome Engineering1▲ 46×1 topic
  34. Immunity1▲ 8.0×3 topics
  35. RNA-Guided1▲ 46×1 topic
  36. Proteasome Inhibitors1▲ 36×2 topics
  37. TGF-ß1▲ 15×3 topics
  38. Cell Culture1▲ 21×2 topics
  39. Mitochondrial Dysfunction1▲ 6.4×3 topics
  40. Monoclonal Antibodies1▲ 15×3 topics

Which research topics does Galapagos (Netherlands) publish most on?

By volume in 2022-now: Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Inflammatory Bowel Disease and Rheumatoid Arthritis Research and Therapies.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 2 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Inflammatory Bowel Disease Genetics 1 works
  4. 4 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 1 works
  6. 6 Inflammatory mediators and NSAID effects Pharmacology 1 works
  7. 7 Photoacoustic and Ultrasonic Imaging Biomedical Engineering 0 works
  8. 8 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  9. 9 Optical Imaging and Spectroscopy Techniques Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.8%not open47.2%

World: 40% of research is openly available.

with international co-authors65.5%domestic only34.5%

World: 18% is written across borders.

How has Galapagos (Netherlands)'s research output changed?

Output in 2022-2025 was 92% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Galapagos (Netherlands) as a percentage of every work published that year, 0.000089% in 2024.

still counting0.000050%0.00010%0.00015%Galapagos (Netherlands)0.000060% in 202520102020

Fractional works of Galapagos (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Leiden

All research institutions in Leiden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Galapagos (Netherlands). Posts are plain text and can be reported.